Every child’s future depends on the research we fund today.
Imagine being told your child has one of the most aggressive brain cancers, and that treatment options are limited. ETMR, a rare and devastating disease, has survival rates historically under 30%, and research for it is severely underfunded. Across all childhood cancers, less than 4% of federal cancer research funding is allocated — leaving families watching their children fight for their lives with little hope. But together, we can change that story. Every child deserves a chance at a future, and your support can fuel life-saving research that brings hope, new treatments, and the possibility of a cure.
Dr. Derek Hanson co-leads the PNOC031 international clinical trial, a groundbreaking effort bringing together experts and patients worldwide to develop standardized treatment plans, collect real-time patient and tumor data, and evaluate improved therapies for ETMR. Early results are already promising, showing longer survival in small cohorts and guiding researchers toward more effective strategies. Funding this work is critical — $200,000 annually is needed to continue this trial and ensure that children with ETMR have access to life-saving research. Every donation, no matter the size, moves us closer to breakthroughs that can save lives. These kids don’t have time to wait — let’s fight for them now. Click the Donate Now button to make your contribution today.
